Literature DB >> 12542915

Kinetics of myo-inositol loading in women of reproductive age.

Pascal M W Groenen1, Hans M W M Merkus, Fred C G J Sweep, Ron A Wevers, Fokje S M Janssen, Régine P M Steegers-Theunissen.   

Abstract

BACKGROUND: Myo-inositol plays a key role in an important intracellular signalling pathway. A deranged myo-inositol metabolism has been associated with neural tube defects. A myo-inositol loading test was performed to investigate the kinetics in healthy women of reproductive age.
METHODS: Five healthy non-obese females [mean age (standard deviation: SD) 22.8 (2.2) years] were recruited at the University Medical Center Nijmegen. Blood samples were drawn fasting and at 20, 40, 60, 90, 180 and 270 min after ingestion of 100 mg/kg body weight of myo-inositol. Urine samples were collected before myo-inositol loading and at 180 and 270 min post-loading. Samples were analysed for serum myo-, epi- and scyllo-inositol and glucose concentrations by gas chromatography. Plasma insulin concentrations were determined by radio-immunoassay. Random intercept models were fitted to evaluate the data.
RESULTS: The estimated myo-inositol and scyllo-inositol concentrations both reached maximum values at 180 min post-loading, respectively: mean (SD) 101.5 (9.2) micro mol/L and 1.09 (0.11) micro mol/L. The estimated plasma insulin and serum glucose concentrations decreased slightly but significantly during the experiment: P < 0.0001 and P < 0.05, respectively. At 180 and 270 min post-loading, urinary myo-inositol concentrations were increased and urinary glucose concentrations were unchanged.
CONCLUSIONS: Myo-inositol enters the bloodstream quickly after oral ingestion and a small amount of myo-inositol is converted to scyllo-inositol. The synthesis of glucose from myo-inositol could not be detected by serum measurements. These data can be used in further research into the association between myo-inositol and neural tube defects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12542915     DOI: 10.1258/000456303321016213

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  8 in total

Review 1.  The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry).

Authors:  Mark P Thomas; Stephen J Mills; Barry V L Potter
Journal:  Angew Chem Int Ed Engl       Date:  2015-12-22       Impact factor: 15.336

2.  Inhibition of lung carcinogenesis and critical cancer-related signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-l-cysteine, indole-3-carbinol and myo-inositol, alone and in combination.

Authors:  Fekadu Kassie; Tamene Melkamu; Abaineh Endalew; Pramod Upadhyaya; Xianghua Luo; Stephen S Hecht
Journal:  Carcinogenesis       Date:  2010-07-05       Impact factor: 4.944

Review 3.  Assessment of Fruit and Vegetables Intake with Biomarkers in Children and Adolescents and Their Level of Validation: A Systematic Review.

Authors:  Li Yuan; Samuel Muli; Inge Huybrechts; Ute Nöthlings; Wolfgang Ahrens; Augustin Scalbert; Anna Floegel
Journal:  Metabolites       Date:  2022-01-28

4.  Scyllo-inositol in normal aging human brain: 1H magnetic resonance spectroscopy study at 4 Tesla.

Authors:  Lana G Kaiser; Norbert Schuff; Nathan Cashdollar; Michael W Weiner
Journal:  NMR Biomed       Date:  2005-02       Impact factor: 4.044

5.  The chemopreventive agent myoinositol inhibits Akt and extracellular signal-regulated kinase in bronchial lesions from heavy smokers.

Authors:  Wei Han; Joell J Gills; Regan M Memmott; Stephen Lam; Phillip A Dennis
Journal:  Cancer Prev Res (Phila)       Date:  2009-03-31

6.  Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study.

Authors:  Franco Lisi; Piero Carfagna; Mario Montanino Oliva; Rocco Rago; Rosella Lisi; Roberta Poverini; Claudio Manna; Elena Vaquero; Donatella Caserta; Valeria Raparelli; Roberto Marci; Massimo Moscarini
Journal:  Reprod Biol Endocrinol       Date:  2012-07-23       Impact factor: 5.211

7.  Properties of scyllo-inositol as a therapeutic treatment of AD-like pathology.

Authors:  Daniela Fenili; Mary Brown; Rebecca Rappaport; JoAnne McLaurin
Journal:  J Mol Med (Berl)       Date:  2007-02-06       Impact factor: 5.606

8.  Myo-Inositol Moderates Glucose-Induced Effects on Human Placental 13C-Arachidonic Acid Metabolism.

Authors:  Oliver C Watkins; Victoria K B Cracknell-Hazra; Reshma Appukuttan Pillai; Preben Selvam; Hannah E J Yong; Neha Sharma; Sathya Narayanan Patmanathan; Amaury Cazenave-Gassiot; Anne K Bendt; Keith M Godfrey; Rohan M Lewis; Markus R Wenk; Shiao-Yng Chan
Journal:  Nutrients       Date:  2022-09-26       Impact factor: 6.706

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.